Adjusting surveillance of emerging infectious disease threat due to climate change in the EUArchived
Adjustments to surveillance practices in the EU will enhance preparedness and public health response to emerging infectious diseases, thereby helping to contain human and economic costs. These are the conclusions of an article published this week in Science magazine, describing a study co-authored by ECDC.
Surveillance of the chikungunya vector Aedes albopictus (Skuse) in Emilia-Romagna (northern Italy): organizational and technical aspects of a large scale monitoring systemArchived
The chikungunya virus outbreak that occurred in 2007 in northern Italy (Emilia-Romagna region) prompted the development of a large scale monitoring system of the population density of Aedes albopictus (Skuse, 1894), comparable at the provincial and municipal levels. In 2007, egg density data presented an aggregated distribution (VMR &gt;1) and Taylor's power law was applied to calculate the minimum number of ovitraps needed to obtain the prefixed precision levels: D=0.2 in the areas where the chikungunya epidemic occurred and D=0.3 in all the other urban areas &gt;600 ha.
Climatic Factors Driving Invasion of the Tiger Mosquito (Aedes albopictus) into New Areas of Trentino, Northern ItalyArchived
The tiger mosquito (Aedes albopictus), vector of several emerging diseases, is expanding into more northerly latitudes as well as into higher altitudes in northern Italy. Changes in the pattern of distribution of the tiger mosquito may affect the potential spread of infectious diseases transmitted by this species in Europe.
No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived
Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North America (3) following the 2009 influenza pandemic vaccination campaigns.
An Inactivated Cell-Culture Vaccine against Yellow FeverArchived
A double-blind, placebo-controlled, dose-escalation, phase 1 study was performed in 60 healthy subjects between 18 and 49 years of age. The two-dose regimen induced the development of neutralizing antibodies in high percentages of the subjects (from 88% to 100% of subjects depending on antigen content)”.
Trends in Imported Chikungunya Virus Infections in Germany, 2006-2009Archived
As parts of Germany are considered potential colonization areas for A. albopictus, monitoring the trends of Chikungunya importation to Germany is a prerequisite for early detection of potential autochthonus cases.
Case Report: Imported Plasmodium knowlesi Malaria in a French Tourist Returning from ThailandArchived
The authors describe a case of imported Plasmodium knowlesi infection in a French tourist acquired in Thailand. The patient had spent a three month beach holiday on the west coast of Thailand including a one month stay on the Island of Ko Payam.
First two autochthonous dengue virus infections in metropolitan France, September 2010Archived
In September 2010, two cases of autochthonous dengue fever were diagnosed in metropolitan France for the first time. The cases occurred in Nice, southeast France, where the vector Aedes albopictus is established.
The extinction of dengue through natural vulnerability of its vectorsArchived
Aedes aegypti is a highly specialized mosquito species feeding predominantly on humans and breeding in artificial water holding containers in urban areas, and currently restricted to subtropical and tropical areas. Williams et al. focus on the reasons why Ae. aegypti once occurred in locations where the mosquito does not occur anymore in Australia, the more temperate drier parts of the country.